Christine Peschken
Overview
Explore the profile of Christine Peschken including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
2209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nishat F, Golding M, Golding M, Merrill K, Merrill K, Protudjer J, et al.
J Rheumatol
. 2025 Feb;
PMID: 39892880
Objective: Young adults with systemic lupus erythematosus (SLE) have physical, cognitive, and psychosocial health issues and other comorbidities that may affect educational attainment and, ultimately, lifetime socioeconomic achievement. We aimed...
2.
Aringer M, Arnaud L, Furie R, Morand E, Peschken C, Hoi A, et al.
Lupus Sci Med
. 2025 Jan;
12(1).
PMID: 39855677
Objectives: Systemic lupus erythematosus (SLE) is a disease with heterogeneous treatment patterns largely based on organ involvement and disease severity. The SLE Prospective Observational Cohort Study (SPOCS) collected data worldwide...
3.
Golding M, Nishat F, Merrill K, Lacaille D, Oguzoglu U, Protudjer J, et al.
Arthritis Care Res (Hoboken)
. 2025 Jan;
PMID: 39748221
Objective: This study examined the lived employment experiences of young adults with childhood- and adult-onset systemic lupus erythematosus (SLE). Methods: Participants were recruited from three Canadian lupus clinics and asked...
4.
Arnaud L, Furie R, Morand E, Aringer M, Peschken C, Desta B, et al.
Lupus Sci Med
. 2023 Dec;
10(2).
PMID: 38123459
Objective: The longitudinal Systemic Lupus Erythematosus Prospective Observational Cohort Study (SPOCS) aims to assess SLE disease course overall and according to type I interferon 4 gene signature (IFNGS). Here, we...
5.
Choi M, Chen I, Clarke A, Fritzler M, Buhler K, Urowitz M, et al.
Ann Rheum Dis
. 2023 Apr;
82(7):927-936.
PMID: 37085289
Objectives: A novel longitudinal clustering technique was applied to comprehensive autoantibody data from a large, well-characterised, multinational inception systemic lupus erythematosus (SLE) cohort to determine profiles predictive of clinical outcomes....
6.
Almeida-Brasil C, Hanly J, Urowitz M, Clarke A, Ruiz-Irastorza G, Gordon C, et al.
Lupus Sci Med
. 2022 Nov;
9(1).
PMID: 36396267
Objective: To evaluate hydroxychloroquine (HCQ)-related retinal toxicity in the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort. Methods: Data were collected at annual study visits between 1999 and 2019. We...
7.
Ugarte-Gil M, Hanly J, Urowitz M, Gordon C, Bae S, Romero-Diaz J, et al.
Ann Rheum Dis
. 2022 Aug;
81(11):1541-1548.
PMID: 35944946
Objective: To determine the independent impact of different definitions of remission and low disease activity (LDA) on damage accrual. Methods: Patients with ≥2 annual assessments from a longitudinal multinational inception...
8.
Choi M, Clarke A, Urowitz M, Hanly J, St-Pierre Y, Gordon C, et al.
Ann Rheum Dis
. 2022 Mar;
81(8):1143-1150.
PMID: 35338033
Objectives: A perception derived from cross-sectional studies of small systemic lupus erythematosus (SLE) cohorts is that there is a marked discrepancy between antinuclear antibody (ANA) assays, which impacts on clinicians'...
9.
Ugarte-Gil M, Mak A, Leong J, Dharmadhikari B, Kow N, Reategui-Sokolova C, et al.
Lupus Sci Med
. 2021 Dec;
8(1).
PMID: 34930819
Objective: In systemic lupus erythematosus (SLE), disease activity and glucocorticoid (GC) exposure are known to contribute to irreversible organ damage. We aimed to examine the association between GC exposure and...
10.
Almeida-Brasil C, Hanly J, Urowitz M, Clarke A, Ruiz-Irastorza G, Gordon C, et al.
Ann Rheum Dis
. 2021 Dec;
81(3):370-378.
PMID: 34911705
Objectives: To evaluate systemic lupus erythematosus (SLE) flares following hydroxychloroquine (HCQ) reduction or discontinuation versus HCQ maintenance. Methods: We analysed prospective data from the Systemic Lupus International Collaborating Clinics (SLICC)...